GSK, Pfizer, Others Targeted In DNA Patent Suit

Law360, New York (May 26, 2011, 1:33 PM ET) -- Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Pfizer Inc. and others were hit with a suit in Colorado on Wednesday alleging they infringe a patent for technology using DNA in genetic analysis.

Australia-based Genetic Technologies Ltd. has filed several suits over its technology since February 2010 and said in a statement that it had so far secured $14.5 million in licensing fees as a result.

Genetic Technologies CEO Paul MacLeman said in a statement that the suit will "further build on our strategy of systematizing [Genetic Technologies’] existing...
To view the full article, register now.